$JHX

James Hardie Industries plc. Stock 12‑Month Price Target Cut to $33.51, Implies 31% Upside

Analysts' average price target for James Hardie Industries (JHX) decreased from $33.7 to $33.51, with a range of $27.88 to $40. This implies a 31% upside from the Oct. 6 closing price. The consensus rating remains 'Buy' among 25 analysts, with 21 Buys, 4 Holds, and 0 Sells.

Original reporting
Published Oct 7, 2026, 7:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 7:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
James Hardie Industries plc. Stock 12‑Month Price Target Cut to $33.51, Implies 31% Upside — source image
Decision brief

The 30-second read

$JHXBearishLow
01

Why it matters

Analyst target reduction may lead to short-term price weakness, but the Buy rating suggests limited downside.

02

Market read

The price‑target cut is a modest downgrade with limited market impact.

03

What to watch

The cut is small and the consensus remains a Buy; underlying fundamentals may still be strong.

Relevance 5/10Novelty 5/10Timing: post-market release

Background

James Hardie Industries plc. is a building materials company listed on the LSE and traded in the US as ADR JHX.

Company-level read

Ticker impact

$JHXBearishMedium confidence
Context

Analyst consensus price target for James Hardie Industries plc. was lowered to $33.51, down from $33.70, indicating a modest downgrade.

Expected impact

downward pressure as the market prices in the lower target

Evidence & confidence

Target reductions typically lead to short-term sell pressure, especially when the cut is modest and the rating remains a Buy.

Market effects

Minor impact on the building materials sector, as James Hardie is a niche player.

Limited to UK/US investors tracking the ADR.

Low

Counterpoint

Some investors may view the modest cut as an overreaction and could look for buying opportunities.

Key entities

  • James Hardie Industries plc.

    Building materials manufacturer

Related articles

$JHXMedAI 8/10

James Hardie (JHX) Crushes Guidance and Raises Its Full-Year Outlook

James Hardie (JHX) reported Q1 FY2027 results with net sales up 64% YoY to $1.475B, adjusted EBITDA up 79% to $422.1M, and raised full-year guidance. The company cited strong execution, cost synergies from the AZEK acquisition, and share gains in its core business. CEO Aaron Erter noted the beat was not due to housing market improvement. Free cash flow doubled to $254.2M, used to pay down debt. Shares trade at a forward P/E of 21.79.

$JHXMed

James Hardie upgrades FY27 cash flow guidance but not earnings, shares dip 5%

James Hardie (JHX) raised its FY27 free cash flow guidance by 20% to ~US$600M, but shares fell 5% as sales and earnings guidance remained unchanged. The company expects to achieve US$125M in cost synergies a year ahead of schedule. Management stated the guidance does not assume a housing recovery. FY26 free cash flow was US$425M, after deal and integration costs of ~US$207M.